Answers are grounded in this paper and cite their sources.
The genome of the major type of human papillomavirus that is associated with anogenital cancer, HPV16, is occasionally found in non-genital cancers, such as oesophageal cancer and various cancers of the head and neck,1 but it is not clear whether human papillomavirus infection is a measurable risk factor for these cancers. Since seropositivity for HPV16 capsids has documented specificity for HPV16 infection,2 serological testing can provide information on whether HPV16 infection is a risk factor for disease development. Previously we found that HPV16 capsid seropositivity was a risk factor for both cervical and anal cancers at odds ratios of 9.5 and 30.4 respectively.3 Therefore we designed a prospective study to assess whether HPV16 infection is also a risk factor for oesophageal or head and neck cancers. During 1968-72 the mobile clinic …
No takes yet. Share an insight, caveat, or question.
Dillner et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: